Perinatal transmission of hepatitis B virus: could hospitals be doing more?

References

• Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat.11, 97–107 (2004).
   PubMed Web of Science ®Google Scholar
• Margolis HS, Coleman PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. JAMA274, 1201–1208 (1995).
   PubMed Web of Science ®Google Scholar
• Jensen L, Heilmann C, Smith E et al. Efficacy of selective antenatal screening for hepatitis B among pregnant women in Denmark: is selective screening still an acceptable strategy in a low-endemicity country? Scand. J. Infect. Dis.35, 378–382 (2003).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. Prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis B surface antigen. MMWR Morb. Mortal. Wkly Rep.37, 341–346, 351 (1988).
   PubMedGoogle Scholar
• Schrag SJ, Arnold KE, Mohle-Boetani JC et al. Prenatal screening for infectious diseases and opportunities for prevention. Obstet. Gynecol.102, 753–760 (2003).
   PubMed Web of Science ®Google Scholar
• Stroffolini T, Bianco E, Szklo A et al. Factors affecting the compliance of the antenatal hepatitis B screening programme in Italy. Vaccine21, 1246–1249 (2003).
   PubMed Web of Science ®Google Scholar
• Papaevangelou V, Hadjichristodoulou C, Cassimos D, Theodoridou M. Adherence to the screening program for HBV infection in pregnant women delivering in Greece. BMC Infect. Dis.6, 84 (2006).
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Global progress toward universal childhood hepatitis B vaccination, 2003. MMWR Morb. Mortal. Wkly Rep.52, 868–870 (2003).
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Progress in hepatitis B prevention through universal infant vaccination – China, 1997–2006. MMWR Morb. Mortal. Wkly Rep.56, 441–445 (2007).
   PubMedGoogle Scholar
• Zhou YH, Wu C, Zhuang H. Vaccination against hepatitis B: the Chinese experience. Chin. Med. J.122, 98–102 (2009).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Implementation of newborn hepatitis B vaccination – worldwide, 2006. MMWR Morb. Mortal. Wkly Rep.57, 1249–1252 (2008).
   PubMedGoogle Scholar
• World Health Organization. Hepatitis B vaccines. Wkly Epidemiol. Rec.84, 405–420 (2009).
   PubMedGoogle Scholar
• Willis BC, Wortley P, Wang SA, Jacques‑Carroll L, Zhang F. Gaps in hospital policies and practices to prevent perinatal transmission of hepatitis B virus. Pediatrics125, 704–711 (2010).
   PubMedGoogle Scholar
• Marcellin P. Hepatitis B and hepatitis C in 2009. Liver Int.29(Suppl. 1), 1–8 (2009).
   PubMed Web of Science ®Google Scholar
• Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. Br. Med. J.332, 328–336 (2006).
   PubMed Web of Science ®Google Scholar
• Beasley RP, Hwang LY, Lee GC et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet2, 1099–1102 (1983).
   PubMed Web of Science ®Google Scholar
• Ip HM, Lelie PN, Wong VC, Kuhns MC, Reesink HW. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet1, 406–410 (1989).
   PubMed Web of Science ®Google Scholar
• del Canho R, Grosheide PM, Mazel JA et al. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982–1992: protective efficacy and long-term immunogenicity. Vaccine15, 1624–1630 (1997).
   PubMed Web of Science ®Google Scholar
• Mast EE, Margolis HS, Fiore AE et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR. Recomm. Rep.54, 1–31 (2005).
   PubMedGoogle Scholar
• Song YM, Sung J, Yang S, Choe YH, Chang YS, Park WS. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur. J. Pediatr.166, 813–818 (2007).
   PubMed Web of Science ®Google Scholar
• Brown RS, Buti M, Goodwin D, Zhang S, Fagan E. Hepatitis B virus (HBV) drugs in pregnancy: findings from the antiretroviral pregnancy registry. J. Hepatol.50(Suppl. 1), S4 (2009).
   PubMed Web of Science ®Google Scholar
• van Nunen AB, de Man RA, Heijtink RA, Niesters HG, Schalm SW. Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients. J. Hepatol.32, 1040–1041 (2000).
   PubMed Web of Science ®Google Scholar
• van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J. Viral Hepat.10, 294–297 (2003).
   PubMed Web of Science ®Google Scholar
• Xu WM, Cui YT, Wang L et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J. Viral Hepat.16, 94–103 (2009).
   PubMed Web of Science ®Google Scholar
• Kazim SN, Wakil SM, Khan LA, Hasnain SE, Sarin SK. Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet359, 1488–1489 (2002).
   PubMed Web of Science ®Google Scholar
• Peters MG. Special populations with hepatitis B virus infection. Hepatology49, S146–S155 (2009).
   PubMed Web of Science ®Google Scholar
• Yue Y, Yang X, Zhang S. Prevention of intrauterine infection by hepatitis B virus with hepatitis B immune globulin: efficacy and mechanism. Chin. Med. J.112, 37–39 (1999).
   PubMedGoogle Scholar
• Xu Q, Xiao L, Lu XB, Zhang YX, Cai X. A randomized controlled clinical trial: interruption of intrauterine transmission of hepatitis B virus infection with HBIG. World J. Gastroenterol.12, 3434–3437 (2006).
   PubMed Web of Science ®Google Scholar
• Yuan J, Lin J, Xu A et al. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study. J. Viral Hepat.13, 597–604 (2006).
   PubMedGoogle Scholar
• Xiao XM, Li AZ, Chen X, Zhu YK, Miao J. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int. J. Gynecol. Obstet.96, 167–170 (2007).
   PubMedGoogle Scholar